This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Mark Hogarth, PhD
Professor and Burnet Senior Principal Research Fellow at Burnet Institute


Mark Hogarth is a Senior Principal Research Fellow of the Burnet Institute having been Director of two major Australian Medical Research Institutes. He holds Professorships at the University of Melbourne and Monash University.

Prof Hogarth’s research teams have made seminal contributions to the molecular discovery of human, non-human primate and mouse Fc receptors and the comprehensive analysis of their genetics, structure and function. His team’s critical insights into actions of Fc receptors in antibody function in normal and pathological immunity underpins the understanding of the action of monoclonal antibody drugs and has led to the candidate biological and chemical therapeutics.

He has advised start-up and major biotech companies on the development of their biological therapeutics and has extensive experience in the translation and commercialisation of biomedical research.

Prof Hogarth distinctions include the Gottschalk Medal (Australian Academy of Science) and the Sir Albert Coates Oration (Albert Coates Foundation).

Agenda Sessions

  • Engineering IgG2 and IgG4 Fc Chains Creates Novel and Potent Effector mAbs

  • LIVE Moderated Panel Discussion and Q&A Including Audience Interaction with Speakers from On-Demand SESSION #6: MODIFYING FC INTERACTIONS TO ENHANCE ANTIBODY THERAPIES - To prepare for this discussion/Q&A, attendees should view the presentations from Session #6 in the Watch On-Demand Sessions Tab prior to this session


Speakers at this event